These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29656869)

  • 1. Comparing Treatment Strategies for Stage I Small-cell lung Cancer.
    Paximadis P; Beebe-Dimmer JL; George J; Schwartz AG; Wozniak A; Gadgeel S
    Clin Lung Cancer; 2018 Sep; 19(5):e559-e565. PubMed ID: 29656869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
    Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
    Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
    Lanni TB; Grills IS; Kestin LL; Robertson JM
    Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
    Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
    J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery and Stereotactic Radiotherapy for Stage I Small-Cell Lung Carcinoma: A 25-Year Experience.
    Robinson LA; Tanvetyanon T; Robinson NA; Bryant S; Bailey A; Reed DR; Dilling T
    Clin Lung Cancer; 2024 Sep; 25(6):537-549.e2. PubMed ID: 38926078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in stereotactic body radiation therapy for stage I small cell lung cancer.
    Stahl JM; Corso CD; Verma V; Park HS; Nath SK; Husain ZA; Simone CB; Kim AW; Decker RH
    Lung Cancer; 2017 Jan; 103():11-16. PubMed ID: 28024690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of stereotactic radiation vs. wedge resection vs. wedge resection plus Cesium-131 brachytherapy in early stage lung cancer.
    Parashar B; Port J; Arora S; Christos P; Trichter S; Nori D; Wernicke AG
    Brachytherapy; 2015; 14(5):648-54. PubMed ID: 25998071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Stereotactic Body Radiotherapy for T1-T2N0 Small Cell Carcinoma According to Addition of Chemotherapy and Prophylactic Cranial Irradiation: A Multicenter Analysis.
    Verma V; Simone CB; Allen PK; Lin SH
    Clin Lung Cancer; 2017 Nov; 18(6):675-681.e1. PubMed ID: 28408183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection.
    Zhong L; Suo J; Wang Y; Han J; Zhou H; Wei H; Zhu J
    World J Surg Oncol; 2020 Feb; 18(1):27. PubMed ID: 32013993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive treatment patterns and survival in stage II non-small cell lung cancer.
    Yan SX; Qureshi MM; Suzuki K; Dyer M; Truong MT; Litle V; Mak KS
    Lung Cancer; 2018 Oct; 124():135-142. PubMed ID: 30268452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SUV
    Ye L; Xu F; Shi S; Zeng Z; Jin X; Huang Y; Lu C; Gu J; Ge D; He J
    Clin Transl Oncol; 2018 Aug; 20(8):1026-1034. PubMed ID: 29327241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
    Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
    Xu L; Zhang G; Song S; Zheng Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection versus stereotactic body radiation therapy in early stage bronchopulmonary large cell neuroendocrine carcinoma.
    Lo H; Abel S; Finley G; Weksler B; Colonias A; Wegner RE
    Thorac Cancer; 2020 Feb; 11(2):305-310. PubMed ID: 31860940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.
    Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Kumano T; Shimizu Y; Tamamura H; Takanaka T; Takemura H
    Ann Thorac Surg; 2019 May; 107(5):1544-1550. PubMed ID: 30458155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
    Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
    Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection.
    Kastelijn EA; El Sharouni SY; Hofman FN; Van Putte BP; Monninkhof EM; Van Vulpen M; Schramel FM
    Anticancer Res; 2015 Oct; 35(10):5607-14. PubMed ID: 26408733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
    Koshy M; Malik R; Weichselbaum RR; Sher DJ
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):344-50. PubMed ID: 25636759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer.
    Lam A; Yoshida EJ; Bui K; Fernando D; Nelson K; Abi-Jaoudeh N
    J Vasc Interv Radiol; 2018 Sep; 29(9):1211-1217.e1. PubMed ID: 30061058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.